A mitochondrial HSP70 (HSPA9B) is linked to miltefosine resistance and stress response in Leishmania donovani
出版年份 2016 全文链接
标题
A mitochondrial HSP70 (HSPA9B) is linked to miltefosine resistance and stress response in Leishmania donovani
作者
关键词
<em class=EmphasisTypeItalic >Leishmania donovani</em>, Miltefosine, Proteomics, Heat-shock proteins
出版物
Parasites & Vectors
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-12-01
DOI
10.1186/s13071-016-1904-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genomic Appraisal of the Multifactorial Basis forIn VitroAcquisition of Miltefosine Resistance in Leishmania donovani
- (2016) P. Vacchina et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Species- and Strain-Specific Adaptation of the HSP70 Super Family in Pathogenic Trypanosomatids
- (2016) Sima Drini et al. Genome Biology and Evolution
- Experimental Resistance to Drug Combinations in Leishmania donovani: Metabolic and Phenotypic Adaptations
- (2015) Maya Berg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutations in the Yeast Hsp70, Ssa1, at P417 Alter ATP Cycling, Interdomain Coupling, and Specific Chaperone Functions
- (2015) Patrick G. Needham et al. JOURNAL OF MOLECULAR BIOLOGY
- Mitochondrial peroxiredoxin functions as crucial chaperone reservoir inLeishmania infantum
- (2015) Filipa Teixeira et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of Leishmania (L.) amazonensis Protein Expression by Host T Cell Dependent Responses: Differential Expression of Oligopeptidase B, Tryparedoxin Peroxidase and HSP70 Isoforms in Amastigotes Isolated from BALB/c and BALB/c Nude Mice
- (2015) Priscila Camillo Teixeira et al. PLoS Neglected Tropical Diseases
- In VitroScreening Test Using Leishmania Promastigotes Stably Expressing mCherry Protein
- (2014) Paola Vacchina et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- LmaPA2G4, a Homolog of Human Ebp1, Is an Essential Gene and Inhibits Cell Proliferation in L. major
- (2014) Brianna Norris-Mullins et al. PLoS Neglected Tropical Diseases
- Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death
- (2013) Jyotsna Mishra et al. EXPERIMENTAL PARASITOLOGY
- Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use
- (2012) S. Sundar et al. CLINICAL INFECTIOUS DISEASES
- Differential expression of proteins in antimony-susceptible and -resistant isolates of Leishmania donovani
- (2011) Neha Biyani et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Expression of a Malarial Hsp70 Improves Defects in Chaperone-Dependent Activities in ssa1 Mutant Yeast
- (2011) Samantha L. Bell et al. PLoS One
- Low Plasma Membrane Expression of the Miltefosine Transport Complex Renders Leishmania braziliensis Refractory to the Drug
- (2009) M. P. Sanchez-Canete et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Histone acetylations mark origins of polycistronic transcription in Leishmania major
- (2009) Sean Thomas et al. BMC GENOMICS
- Characterization of an ABCG-Like Transporter from the Protozoan Parasite Leishmania with a Role in Drug Resistance and Transbilayer Lipid Movement
- (2008) E. Castanys-Munoz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis of BODIPY-labeled alkylphosphocholines with leishmanicidal activity, as fluorescent analogues of miltefosine
- (2008) Valentín Hornillos et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Distinct mitochondrial HSP70 homologues conserved in various Leishmania species suggest novel biological functions
- (2008) Rodrigo M. Campos et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- A novel ATP-binding cassette transporter, ABCG6 is involved in chemoresistance of Leishmania
- (2007) Somdeb BoseDasgupta et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More